NaviDKD® and Compass™
A Powerful Duo for Advanced Detection and Intelligent Care
NaviDKD, our clinically validated predictive screening, offers transformative foresight, identifying people with diabetes at risk of kidney disease up to 12 years ahead of standard diagnostic methods. Powered by Compass™, our AI-driven platform, we convert intricate lab data into straightforward risk evaluations and personalized, actionable treatment plans. Together, NaviDKD and Compass pioneer a transformative approach to diabetes-related kidney disease (DKD), combining predictive science with digital innovation.
Visit Our Team in the StartUp Health Pavilion
We're thrilled to announce our inaugural presence at this year's HLTH conference within the StartUp Health Pavilion. Join us at booth #5746-2 to explore firsthand how Journey Biosciences is revolutionizing the early detection of diabetes-related kidney disease. Engage with our team, experience our solution, and discover the transformative potential of our technology.
Meet With Us
If you're attending HLTH 2023, we'd love to connect. Whether you're curious about our technology, interested in potential partnerships, or simply looking to discuss the future landscape of diabetes-related healthcare, we're here and ready. Fill out the form below and we'll schedule a time as the conference get's closer. We look forward to meeting you.